It was also demonstrated that telmisartan, angiotensin II type 1 receptor blocker and thiorphan, neprilysin inhibitors reduced CK-MB and LDH in STZ-induced cardiomyopathy in the rats model. This evidence concerns the gene AGTR1 and cardiomyopathy.